.Attributes Medication, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Perspective requires incorporation of people with MASLD and also dimension of liver end results in cardio-- renal-- metabolic trials, when records suggest mechanistically probable perks and also medical safety and security-- and lays out points to consider for trial concept as well as regulative commendation.